There has been a lot written recently about positron emission tomography (PET) scans. The following is a link to an overview published in Medical News Today on December 16th.
General Patient Information
Radical prostatectomy can be a very difficult operation. The very best urological surgeons specialize in the prostate gland. They do a lot of these procedures annually. How do you find the right surgeon? The Prostate Cancer Foundation has published a checklist of things to consider before choosing the right surgeon. 1) First, locate a high-volume more »
An analysis by Canadian and Australian scientists of 27 previous studies led them to conclude that there is a significant association between alcohol use and prostate cancer risk. The more men drink, the greater the risk. Even low levels of drinking (up to two drinks a day) were associated with an 8 to 23 percent more »
When you’re diagnosed with prostate cancer, the doctor will determine how far the disease has progressed and tell you what stage the cancer is in. The staging shows how the tumor has grown and if the cancer has spread to other parts of the body. It’s important to know this information so that patients can more »
It isn’t often that a research finding appears in 4-5 e mail or other publications but such is the case herein. Researchers at Stanford University School of Medicine published a study entitled “Association Between Androgen Deprivation Therapy and the Risk of Dementia” in the journal Journal of the American Medical Association Oncology. They reported that men more »
In a study published online on Oct. 20th in the Journal of the American Medical Association (JAMA) Oncology, more than 90 percent of men in Sweden who have very low-risk prostate cancer choose close monitoring rather than immediate treatment — and more American men should use that option, researchers say. In a study of nearly more »
The following is a summary of an article written by Mark Moyad M.D., Jenkins/Pokempner Director of Complementary & Alternative Medicine at the University of Michigan Medical Center. It was published in the August 2016 issue of Prostate Insights from the Prostate Cancer Research Institute (PCRI). Cancer-related fatigue (CRF) can occur in as many as 60-90% more »
To understand better the benefits of vitamin D, watch this video shared by the Prostate Cancer Research Institute where Dr. Charles Myers, a medical oncologist and prostate cancer patient himself, talks about the use of vitamin D, how patients can benefit from it and how its deficiency can worsen patients’ health condition. In this 2-minute more »
If your doctor suspects you may have prostate cancer because of an elevated prostate-specific antigen (PSA) level, you might want to ask for a repeat PSA test to confirm the results, says a new Canadian study. It could save you from undergoing an unnecessary prostate biopsy that could entail serious complications. Of 1,268 men who more »
In an article published in the journal Cancer Epidemiology, Biomarkers & Prevention (2016, Jan. 25), researchers at the National Cancer Institute (NCI) of the National Institutes of Health (NIH) document an association between higher serum levels of vitamin D and an increased chance of surviving prostate cancer. The current investigation included 1,000 participants in the more »
Prostate cancer patients who undergo radiation treatment, especially brachytherapy, are at increased relative risk of bladder cancer according to new study findings presented at the American Urological Association 2016 annual meeting by researchers from Albert Einstein College of Medicine in New York. This increased relative risk occurs predominantly after 10 years. Bladder tumors found in more »
An April 4th, 2011 website post described two studies from Johns Hopkins and UCLA which concluded that pomegranate extract increased PSA doubling time (PSADT) in men with prostate cancer. Recently, the National Cancer Institute (NCI) has updated its information from human studies of pomegranate extract. In a study reported in 2006, researchers observed the effects more »
In a very informative seven minute video clip recently posted on Prostate Cancer News Today, Dr. Alicia K. Morgans, an Assistant Professor of Medicine in the subject of hematology and oncology, at the Vanderbilt-Ingram Cancer Center discusses prostate cancer and bone metastasis. She discusses what these diseases entail, how they spread, where in the body they spread, more »
Prostate Cancer News Today is a weekly e mail from Bayer Healthcare that contains 3-4 articles referencing various aspects of prostate cancer. An e mail received May 16th, 2016 contained an article called “Finding Out About Prostate Cancer Clinical Trials.” The article was one of the best references I have seen to provide information about more »
A Northwestern University study of 190 men of median age 64 having their prostate removed found those with low vitamin D levels were more likely to have rapidly growing tumors than those with normal levels of the “sunshine” vitamin. The study was published on-line in the Journal of Clinical Oncology. The researchers found that nearly more »
Prostate Cancer News Today recently sent an e mail summarizing the twelve currently-approved drug treatments for prostate cancer. Rather than reproducing the list here, I am providing a link to the article.
A large study (see the Cancer Network Oncology link) from Harvard Medical School and Brigham and Women’s Hospital in Boston suggests that men receiving testosterone-suppressing (hormone) therapy (ADT) for prostate cancer may be at increased risk of developing depression. The findings, published online April 11th in the Journal of Clinical Oncology, are based on Medicare more »
While the average age of prostate cancer diagnosis is 66, rates are rising in men age 55 and younger. In my own case, I was initially diagnosed with prostate cancer at the age of 54, which is now over twenty years ago. Here are a few things to consider about screening, treatment and prevention. 1) more »
An excellent review by Dr. Jonathan Epstein of Johns Hopkins was just published in the Prostate Cancer Research Institute Insights. Please see the entire link for the questions and answers from Dr. Epstein.
The following comes from the Prostate Cancer Foundation (PCF). Tomatoes are rich in lycopene, which is one of the most well-studied antioxidants in the fight against prostate cancer. Recent research suggests that lycopene may inhibit prostate cancer growth and development of metastases. Cooking tomatoes and consuming them with healthy fats (such as olive oil) increases more »